MERIDIA DIET DRUG
meridia side effects

 

Meridia Side Effects

Meridia side effects have been linked to the deaths of 29 people since the drug’s 1998 debut. Serious Meridia side effects have led to petitions for a recall of the drug currently prescribed to over 9 million people. Meridia side effects have already caused the suspension of this drug in Italy, where 2 deaths occurred. Meridia side effects include arrhythmia and high blood pressure, and since the drug is used by the obese, Meridia side effects can compound existing conditions and often prove deadly.

In 1997, an FDA advisory committee stated that Meridia side effects outweighed its benefits. In trials, takers of Meridia lost 7-10 pounds more than regular dieters. Meridia side effects also led an FDA medical officer to recommend the drug not be approved, since Meridia side effects showed a potential for cardiac complications in trials. Despite serious concerns about the lethal potential of Meridia side effects, the FDA approved its use and the drug was on the market in 1998.

If Meridia side effects have caused you or a loved one to suffer injury, you may wish to seek representation. Meridia side effects such as hypertension and heart problems can lead to serious long-term problems. Attorneys familiar with Meridia side effects can help you to get the compensation to which you are entitled.

If you would like to speak to an expert Meridian diet drug attorney, contact us.

Contact a Meridia Side Effects Lawyer

Meridia Resource provides you with Meridia information and puts you in contact with a Meridia lawyer. To contact an Meridia lawyer please click here to receive your free consultation.

The FDA is currently reviewing the safety implications that have been associated with Meridia in response to Public Citizen’s petition. Public Citizen has petitioned for the removal of four other FDA approved drugs since 1996 and three of the drugs ended up being banned and one severely restricted.

Browse through these websites to learn more about various legal topics.